Related Experiment Video
Updated: Dec 27, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Transradial Percutaneous Coronary Intervention in Patients With Advanced Chronic Kidney Disease
Fumiaki Yashima1, Taku Inohara2, Yohei Numasawa3
1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan; Department of Cardiology, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
Insights
Transradial intervention (TRI) may reduce acute kidney injury and the need for hemodialysis in percutaneous coronary intervention (PCI) patients with advanced chronic kidney disease (CKD). Further research is needed to confirm TRI benefits in this population.
Area of Science:
- Cardiology
- Nephrology
- Interventional Cardiology
Background:
- Transradial intervention (TRI) generally shows better outcomes than transfemoral intervention (TFI) in percutaneous coronary intervention (PCI).
- Patients with advanced chronic kidney disease (CKD) face higher risks of complications and TRI is often avoided due to potential impact on arteriovenous fistula creation for hemodialysis.
- Limited data exists on the safety and efficacy of TRI specifically in advanced CKD patients undergoing PCI.
Purpose of the Study:
- To assess the impact and outcomes of transradial intervention (TRI) compared to transfemoral intervention (TFI) in patients with advanced chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI).
Main Methods:
- Analysis of consecutive PCI patients with advanced CKD (eGFR <30 mL/min/1.73 m²).
- Comparison of periprocedural bleeding, acute kidney injury (AKI), and need for hemodialysis initiation between TRI and TFI groups.
- 1:1 propensity score matching was used to control for baseline differences between the TRI and TFI groups.
Main Results:
- After propensity matching, TRI was associated with significantly reduced risks of periprocedural acute kidney injury (AKI) (12.4% vs. 26.5%) and hemodialysis initiation (3.1% vs. 12.4%) compared to TFI.
- TRI showed a trend towards lower rates of bleeding complications, though not statistically significant (1.9% vs. 6.2%).
- The study included 324 patients (mean age 74.9 years, 63.6% male) after matching.
Conclusions:
- Transradial intervention (TRI) may offer benefits over transfemoral intervention (TFI) in percutaneous coronary intervention (PCI) patients with advanced chronic kidney disease (CKD).
- TRI appears to reduce the risk of acute kidney injury and the need for subsequent hemodialysis in this vulnerable patient group.
Background:
Multiple randomized clinical trials have demonstrated that transradial intervention (TRI) improves clinical outcomes after percutaneous coronary intervention (PCI) compared with transfemoral intervention (TFI). However, chronic kidney disease (CKD) patients have more procedure-related complications; TRI is frequently avoided for future creation of arteriovenous fistulas essential for hemodialysis. Therefore, limited information on TRI among CKD patients exists. We aimed to assess the impact of TRI on CKD patients.
Methods:
Consecutive PCI patients with advanced CKD registered in a multicenter Japanese registry between 2008 and 2017 (N = 20,420) were analyzed. Advanced CKD was defined as estimated glomerular filtration rate <30 mL/min/1.73 m2. Outcomes of interest were periprocedural bleeding (transfusion or decreasing hemoglobin by >3.0 g/dL within 72 h after PCI), acute kidney injury (AKI: absolute increase of 0.3 mg/dL or a relative increase of 50% in serum creatinine from baseline), and hemodialysis initiation after PCI. To account for baseline differences between patients with TRI and TFI, 1:1 propensity matching was performed.
Results:
Overall, 498 patients (3.7%) had advanced CKD, and 199 (40.0%) underwent TRI. After propensity matching, 324 patients were included (age, 74.9 ± 9.9 years; male, 63.6%; ACS, 46.0%). TRI was associated with reduced periprocedural AKI risks (12.4% versus 26.5%; p < 0.01) and hemodialysis initiation (3.1% versus 12.4%; p = 0.01) compared with TFI. TRI showed a trend toward lower rates of bleeding complications than those of TFI, but the difference was not statistically significant (1.9% versus 6.2%; p = 0.15).
Conclusions:
TRI might be beneficial over TFI in PCI patients with advanced CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Continuous Renal Replacement Therapy
Cardiac Catheterization I: Pre-Procedure Overview
Kidney Transplant I: Introduction

